Cargando…
Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer
Rationale: Dense desmoplastic stroma is a fundamental characteristic of pancreatic ductal adenocarcinoma (PDAC) and comprises up to 80% of the tumor mass. Type I collagen is the major component of the extracellular matrix (ECM), which acts as a barrier to impede the delivery of drugs into the tumor...
Autores principales: | Li, Yuanke, Zhao, Zhen, Lin, Chien-Yu, Liu, Yanli, Staveley-OCarroll, Kevin F., Li, Guangfu, Cheng, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797682/ https://www.ncbi.nlm.nih.gov/pubmed/33500719 http://dx.doi.org/10.7150/thno.53102 |
Ejemplares similares
-
The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
por: Wang, Lai Mun, et al.
Publicado: (2015) -
The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration
por: Watt, Jennifer, et al.
Publicado: (2013) -
The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy
por: Qi, Xiaoqiang, et al.
Publicado: (2022) -
The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities
por: Masugi, Yohei
Publicado: (2022) -
Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer
por: Liu, Dai, et al.
Publicado: (2018)